Immunology - Interleukin 6 (IL-6) Physiology and IL-6 Antagonist Pharmacology
Case description
IL-6 is another potent proinflammatory cytokine and mediator of the acute phase response. It is produced by immune cells in response to inflammation or infection. The IL-6 receptor is a membrane bound receptor which require co receptors gp130. Gp130 initiates intracellular cascade of events through the JAK/STAT of MAPK pathway which ultimately leads to the activation of transcription factor involved in activating genes that will promote inflammation and the effects of IL-6.
Tocilizumab is a monoclonal antibody against the IL-6 receptor used in RA; JIA; Castleman disease; GCA.
Where do I get my information from: http://armandoh.org/resource
Facebook:
https://www.facebook.com/ArmandoHasudungan
Support me:
http://www.patreon.com/armando
Instagram:
http://instagram.com/armandohasudungan
Twitter:
https://twitter.com/armandohasudung
SPECIAL THANKS:
Patreon members
Tocilizumab is a monoclonal antibody against the IL-6 receptor used in RA; JIA; Castleman disease; GCA.
Where do I get my information from: http://armandoh.org/resource
Facebook:
https://www.facebook.com/ArmandoHasudungan
Support me:
http://www.patreon.com/armando
Instagram:
http://instagram.com/armandohasudungan
Twitter:
https://twitter.com/armandohasudung
SPECIAL THANKS:
Patreon members
Are you Health Professional?
Register now, join the community for free access.
GET ALL THE BENEFITS THAT MEDTUBE PLATFORM OFFERS:
- Unlimited access to the largest e-library of professional videos, images, documents, courses
- Connect with peers 350,000+ Healthcare Professionals from 180 countries
- Upload and share your own cases, ask questions and discuss
- Create your professional profile and build personal recognition worldwide
- Stay up-to-date with innovative techniques, treatments, guidelines, discoveries in your fields of interest; be notified
- You are informed about innovative treatments, techniques and innovations in medicine
